Biotech · Private company · Cambridge, MA, US
Acousticabio, Inc.
Track this companyFree. Adds Acousticabio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Enabling subcutaneous delivery of antibodies via microgel-based, ultra-high concentration formulationsFiscal year 2026 · $931.5KNIH RePORTER 1R44TR006344-01 · fetched Nov 12, 2026
- Enabling Subcutaneous Delivery of Therapeutic Monoclonal Antibodies via Hydrogel MicroparticlesFiscal year 2024 · $53KNIH RePORTER 3R43TR004761-01S1 · fetched Nov 12, 2026
- High-Dose and Sustained Delivery of HIV-1 Broadly Neutralizing Antibodies via Subcutaneous Injection of Hydrogel-based Microparticle FormationsFiscal year 2024 · $295.1KNIH RePORTER 75N93024C00047-0-9999-1 · fetched Nov 12, 2026